Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
In Vitro studies have shown promise against viruses similar to the bird flu virus BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- ...
Pharmabiz2d
Bioxytran inks non-disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens
Bioxytran inks non-disclosure agreement with University of Georgia to evaluate Galectin antagonists for bird flu treatment in chickens: Boston Friday, March 21, 2025, 15:00 Hrs [I ...
BIOXYTRAN, INC.: Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
In Vitro studies have shown promise against viruses similar to the bird flu virus BOSTON, MASSACHUSETTS, March 19, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the "Company"), a clinical st ...
Morningstar4d
Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens
The collaboration will focus on evaluating Bioxytran’s galectin antagonist as a potential treatment for chickens infected with Bird Flu. The research will be led by Dr. Daniel Perez, a renowned ...
Galecto Reports Full-Year 2024 Financial Results
Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ...
Stocktwits on MSN2d
Why Retail Traders Are Rushing Into Small-Cap Wellgistics Health Weeks After Its Nasdaq Debut
Wellgistics Health, Inc., a holding company focused on pharmaceuticals and healthcare services, has drawn significant retail ...
AZoLifeSciences on MSN5d
Understanding How Tumor-Derived Extracellular Vesicles Enter Target Cells
Most cells in the body send out little messengers called extracellular vesicles that carry proteins, lipids, and other bioactive molecules to other cells, playing an important role in intercellular ...